DBV Technologies ADR [DBVT] stock is trading at $16.98, up 22.16%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DBVT shares have gain 30.82% over the last week, with a monthly amount glided 20.94%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DBV Technologies ADR [NASDAQ: DBVT] stock has seen the most recent analyst activity on December 03, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $35. On January 04, 2023, upgrade upgraded it’s rating to Buy. Goldman downgraded its rating to a Sell. Goldman downgraded its rating to a Neutral and reduced its price target to $1.50 on May 10, 2022. Societe Generale upgraded its rating to Buy for this stock on September 14, 2021. In a note dated January 22, 2021, Societe Generale downgraded an Sell rating on this stock.
DBV Technologies ADR [DBVT] stock has fluctuated between $2.74 and $18.00 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. DBV Technologies ADR [NASDAQ: DBVT] shares were valued at $16.98 at the most recent close of the market. An investor can expect a potential return of 106.12% based on the average DBVT price forecast.
Analyzing the DBVT fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -52.19%, Pretax Profit Margin comes in at -52.35%, and Net Profit Margin reading is -52.4%. To continue investigating profitability, this company’s Return on Assets is posted at -0.85, Equity is -2.87 and Total Capital is -1.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.88 points at the first support level, and at 12.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.29, and for the 2nd resistance point, it is at 19.60.
Ratios To Look Out For
For context, DBV Technologies ADR’s Current Ratio is 1.80. Also, the Quick Ratio is 1.80, while the Cash Ratio stands at 2.09.
Transactions by insiders
Recent insider trading involved Mohideen Pharis, Chief Medical Officer, that happened on Nov 20 ’25 when 6496.0 shares were sold. Chief Medical Officer, Mohideen Pharis completed a deal on Nov 21 ’25 to sell 1624.0 shares. Meanwhile, Chief Medical Officer Mohideen Pharis sold 464.0 shares on Jul 29 ’25.
